Chrystal Louis
Director Técnico/Científico/I+D en TSCAN THERAPEUTICS, INC. .
Cargos activos de Chrystal Louis
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 08/04/2024 | - |
Historial de carrera de Chrystal Louis
Antiguos cargos conocidos de Chrystal Louis.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2022 | 01/03/2024 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Corporate Officer/Principal | 01/07/2020 | 01/11/2022 |
| CELGENE | Corporate Officer/Principal | 01/10/2016 | 01/01/2019 |
Formación de Chrystal Louis.
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Southwestern University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Chrystal Louis
- Experiencia
